The cell and advanced therapies supply chain is complex,with several legacy challenges, such as those related to patient scheduling,resource planning, inventory management, and deliverable tracking. A number ofinnovative, software-enabled systems are available / under development tomitigate the aforementioned concerns and simplify the management ofbiopharmaceutical supply chains.
Toorder this 510+ page report, which features 185+ figures and 400+ tables,please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html
The USD 1.5 billion (by 2030)financial opportunity within the cell and advanced therapy supply chainmanagement software solutions market has been analyzed across the following segments:
§ Application area
§ Sample collection andprocessing
§ Manufacturing
§ Logistics
§ Patientidentification and treatment follow-up
§ Type of softwaresolution
§ Cell orchestrationplatform
§ Enterprisemanufacturing system
§ Inventory managementsystem
§ Laboratoryinformation management system
§ Logistics managementsystem
§ Patient managementsystem
§ Quality managementsystem
§ Mode of Deployment
§ Cloud-based solution
§ On-premises solution
§ Scale of Operation
§ Clinical
§ Commercial
§ End user
§ Biobank
§ Cell therapy lab /commercial organization
§ Hospital / medicalcenter
§ Research institute
§ Key geographicalregions
§ North America
§ Europe
§ Asia Pacific
§ Rest of the world
The Cell and Advanced Therapies Supply ChainManagement Market: Focus onTechnological Solutions (Cell Orchestration Platforms, Enterprise ManufacturingSystems, Inventory Management Systems, Laboratory Information ManagementSystems, Logistics Management Systems, Patient Management Systems, QualityManagement Systems, Tracking & Tracing Systems, and Other Software),2019-2030 report features the following companies, which weidentified to be key players in this domain:
§ Be The MatchBioTherapies®
§ Brooks Life Sciences
§ Clarkston Consulting
§ Cryoport
§ Haemonetics
§ Hypertrust PatientData Care
§ Lykan Bioscience
§ MAK-SYSTEM
§ MasterControl
§ SAP
§ SAVSU Technologies
§ sedApta Group
§ Stafa CellularTherapy
§ Title21 HealthSolutions
§ TraceLink
§ TrakCel
§ Vineti
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Current Market Landscape
5. Company Competitiveness Analysis
6. Cell and Advanced Therapies Supply Chain Management: CompanyProfiles
7. Supply Chain Orchestration Platform: Emerging Trends and KeyPlayers
8. Funding and Investment Analysis
9. Partnerships and Collaborations
10. Supply Chain Utilization Use Cases
11. Stakeholder Needs Analysis
12. Cost Savings Analysis
13. Market Forecast
14. Executive Insights
15. Concluding Remarks
16. Appendix 1: List of Additional Supply Chain ManagementSoftware Solutions
17. Appendix 2: Tabulated Data
18. Appendix 3: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
